Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Lot Number: GR12-032026-4 Purity: 99.9% Date: April 19, 2026 View COA Archive Peptide Research Overview Peptides are short chains of amino acids studied for their role in cellular signaling and molecular interactions
Cost of medication AED 1,734 AED 743 AED 743 Scientific name Tirzepatide (dual GIP + GLP-1 receptor agonist) Semaglutide (GLP-1 receptor agonist) Semaglutide (GLP-1 receptor agonist) Blood Panel Chronic weight management in adults with BMI 30 or BMI 27 with at least 1 metabolic condition, e.g., diabetes, hypertension Chronic weight management in adults & adolescents 12 years with BMI 30 or BMI 27 with at least 1 comorbidity Type 2 diabetes Expected weight loss based on studies -21% at 72 weeks based on the SURMOUNT-1 study -15% at 68 weeks based on the STEP-1 study Similar to Wegovy Reduction in diabetes markers Results from SURPASS-CVOT study pending SELECT trial: 20 % MACE over ~3 y
The BMI requirements for GLP-1 medications vary by indication and insurance provider, and understanding these thresholds helps with the practical aspects of obtaining treatment
These medications also show cardiovascular and renal benefits, such as reducing blood pressure, improving endothelial function, and lowering the risk of cardiovascular events like myocardial infarction and stroke [6][16]
Oral semaglutide and cardio-vascular outcomes in patients with type 2 diabetes
Patients who pair it with meaningful lifestyle changes, such as healthier eating habits and regular exercise, achieve better and more sustainable results
